AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 64 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $936,139 | +438.0% | 62,618 | +163.1% | 0.00% | +300.0% |
| Q1 2021 | $174,000 | -72.6% | 23,803 | -78.4% | 0.00% | -80.0% |
| Q4 2020 | $636,000 | +39.5% | 110,179 | +43.6% | 0.01% | -16.7% |
| Q3 2020 | $456,000 | -24.8% | 76,732 | -34.8% | 0.01% | -40.0% |
| Q2 2020 | $606,000 | – | 117,710 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 835,000 | $6,112,000 | 0.90% |
| NEA Management Company, LLC | 3,952,958 | $28,936,000 | 0.65% |
| X-Square Capital, LLC | 101,248 | $741,000 | 0.34% |
| Monashee Investment Management LLC | 250,000 | $1,830,000 | 0.28% |
| Cormorant Asset Management, LP | 1,500,000 | $10,980,000 | 0.24% |
| CLOUGH CAPITAL PARTNERS L P | 300,000 | $2,196,000 | 0.10% |
| Maven Securities LTD | 225,000 | $1,604,000 | 0.07% |
| XTX Topco Ltd | 15,292 | $112,000 | 0.05% |
| PERSONAL CFO SOLUTIONS, LLC | 23,000 | $168,000 | 0.04% |
| PDT Partners, LLC | 46,666 | $342,000 | 0.02% |